Thermo Fisher Scientific Earnings & Forecasts

Thermo Fisher Scientific (TMO) earnings history, EPS estimates, revenue forecasts and company guidance.

Earnings Per Share (Non-GAAP)

분기별 실적 서프라이즈 금액

회계 분기	보고된 날짜	실제 EPS	예상 EPS	놀라다 %
Q2	Jul 23, 2026	$6.03	$5.71	5.60 %
Q1	Apr 23, 2026	$5.44	$5.23	4.02 %
Q4	Jan 29, 2026	$6.57	$6.44	2.02 %
Q3	Oct 22, 2025	$5.79	$5.50	5.27 %

Quarterly Revenue (Billions)

분기별 수익 깜짝 금액

회계 분기	보고된 날짜	실제 수익	예상 수익	놀라다 %
Q2	Jul 23, 2026	$11.99B	$11.70B	2.54 %
Q1	Apr 23, 2026	$11.01B	$10.85B	1.38 %
Q4	Jan 29, 2026	$12.22B	$11.91B	2.54 %
Q3	Oct 22, 2025	$11.12B	$10.91B	1.92 %

Thermo Fisher Scientific Guidance

Thermo Fisher Scientific (TMO)은 지난 7월 23, 2026에 fiscal year 2026의 실적 전망을 발표했습니다. 회사는 주당순이익을 $24.93 - $25.33 범위로 전망했으며, 이는 시장 컨센서스 EPS 추정치인 $24.85보다 높은 수치입니다. Thermo Fisher Scientific는 또한 해당 기간의 매출을 $47.4B - $48.1B 범위로 전망했습니다.

이전 가이던스와 비교하여 Thermo Fisher Scientific는 주당순이익(EPS) 전망치를 이전 범위인 상향 조정됨에서 $24.64 - $25.12로 상향 조정했습니다. 매출 측면에서는 회사가 매출 전망치를 이전 범위인 유지됨에서 $47.3B - $48.1B로 상향 조정했습니다.

Thermo Fisher Scientific은 17과 10월 26, 2022 사이에 7월 23, 2026개의 지침 업데이트를 발표했습니다. During this period, the company raised its outlook 6 times and lowered it 4 times, providing investors with insight into management's evolving expectations.

Recent Earnings Results

Metric	Q2 '26	Q1 '26	Q4 '25	Q3 '25
Earnings Per Share (Non-GAAP)
Estimate	$5.71	$5.23	$6.44	$5.50
Actual	$6.03	$5.44	$6.57	$5.79
Surprise	+5.60%	+4.02%	+2.02%	+5.27%
Revenue
Estimate	$11.70B	$10.85B	$11.91B	$10.91B
Actual	$11.99B	$11.01B	$12.21B	$11.12B
Surprise	+2.54%	+1.38%	+2.54%	+1.92%

Analyst Estimates — Forward PeriodsSource: Wall Street consensus

Metric	Q3 '26E	Q4 '26E	Q1 '27E	Q2 '27E
Earnings Per Share (Non-GAAP)
Consensus	$6.40	$7.28	$5.93	$6.55
Revenue
Consensus	$11.94B	$12.91B	—	—

More with Benzinga EdgeGet Access

PRO
Thermo Fisher Scientific Raises FY2026 Adj EPS Guidance from $24.64-$25.12 to $24.93-$25.33 vs $24.86 Est; Raises FY2026 Sales Guidance from $47.300B-$48.100B to $47.400B-$48.100B vs $47.767B Est

Thermo Fisher Scientific (NYSE:TMO) raises FY2026 Adj EPS guidance from $24.64-$25.12 to $24.93-$25.33 vs $24.86 analyst estimate. Raises FY2026 sales outlook from $47.300 billion-$48.100 billion to $47.400

Benzinga Newsdesk

Earnings Scheduled For July 23, 2026

Companies Reporting Before The Bell • Altisource Portfolio (NASDAQ:ASPS) is estimated to report quarterly earnings at $0.18 per share on revenue of $42.90 million. • Dime Commercial (NYSE:DCOM) is expected to report

Benzinga Insights

PRO
Thermo Fisher Scientific Q2 Adj. EPS $6.03 Beats $5.71 Estimate, Sales $11.994B Beat $11.701B Estimate

Thermo Fisher Scientific (NYSE:TMO) reported quarterly earnings of $6.03 per share which beat the analyst consensus estimate of $5.71 by 5.6 percent. This is a 12.5 percent increase over earnings of $5.36 per share from

Benzinga Newsdesk

Thermo Fisher Scientific Inc